X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (471) 471
Publication (102) 102
Book Chapter (6) 6
Conference Proceeding (6) 6
Book / eBook (4) 4
Patent (4) 4
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (284) 284
oncology (237) 237
index medicus (185) 185
male (164) 164
female (149) 149
middle aged (138) 138
lung neoplasms - drug therapy (136) 136
aged (133) 133
carcinoma, non-small-cell lung - drug therapy (130) 130
lung neoplasms - pathology (111) 111
chemotherapy (104) 104
adult (97) 97
antineoplastic combined chemotherapy protocols - therapeutic use (88) 88
carcinoma, non-small-cell lung - pathology (79) 79
prognosis (72) 72
respiratory system (68) 68
cancer (66) 66
aged, 80 and over (64) 64
treatment outcome (63) 63
neoplasm staging (56) 56
antineoplastic agents - therapeutic use (53) 53
cisplatin (53) 53
lung neoplasms - mortality (53) 53
carcinoma, non-small-cell lung - mortality (50) 50
cisplatin - administration & dosage (50) 50
survival (47) 47
lung neoplasms - genetics (46) 46
hematology, oncology and palliative medicine (42) 42
lung cancer (42) 42
pemetrexed (41) 41
survival rate (41) 41
care and treatment (38) 38
gemcitabine (38) 38
carcinoma (37) 37
carcinoma, non-small-cell lung - genetics (37) 37
non-small cell lung cancer (37) 37
trial (35) 35
lung cancer, non-small cell (34) 34
survival analysis (34) 34
deoxycytidine - analogs & derivatives (33) 33
cell lung-cancer (32) 32
deoxycytidine - administration & dosage (32) 32
retrospective studies (32) 32
metastasis (31) 31
tumors (31) 31
combination (30) 30
guanine - analogs & derivatives (30) 30
disease-free survival (29) 29
lung neoplasms - surgery (28) 28
paclitaxel (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
carboplatin (26) 26
pulmonary/respiratory (26) 26
surgery (26) 26
carboplatin - administration & dosage (25) 25
immunohistochemistry (25) 25
lung neoplasms - metabolism (25) 25
docetaxel (24) 24
expression (24) 24
follow-up studies (23) 23
research (23) 23
thymidylate synthase (23) 23
double-blind (22) 22
glutamates - administration & dosage (22) 22
guanine - administration & dosage (22) 22
phase-iii trial (22) 22
analysis (21) 21
carcinoma, non-small-cell lung - surgery (21) 21
clinical trials as topic (21) 21
non-small-cell lung cancer (21) 21
nsclc (21) 21
carcinoma, non-small-cell lung - metabolism (20) 20
diagnosis (20) 20
immunotherapy (20) 20
malignant pleural mesothelioma (20) 20
medicine & public health (20) 20
open-label (20) 20
therapy (20) 20
paclitaxel - administration & dosage (19) 19
pathology (19) 19
radiotherapy (19) 19
randomized controlled trials as topic (19) 19
adenocarcinoma (18) 18
antineoplastic agents - pharmacology (18) 18
bevacizumab (18) 18
disease progression (18) 18
gene expression (18) 18
lung neoplasms - therapy (18) 18
prostate cancer (18) 18
cell line, tumor (17) 17
chemotherapy, adjuvant (17) 17
gene expression regulation, neoplastic (17) 17
phase-iii (17) 17
adenocarcinoma - pathology (16) 16
cisplatin - therapeutic use (16) 16
gefitinib (16) 16
protein kinase inhibitors - therapeutic use (16) 16
quality of life (16) 16
adjuvant chemotherapy (15) 15
animals (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2018, Second edition., ISBN 0323523579
Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today's best approaches to lung... 
Thoracic Neoplasms
eBook
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 874 - 886
Journal Article
Cancer, ISSN 0008-543X, 12/2017, Volume 123, Issue 24, pp. 4764 - 4766
Precision medicine quite likely will be implemented at a different pace than originally hypothesized, but it is definitely the way to move forward. Even from a... 
CELL LUNG-CANCER | HISTOLOGY MATTERS | ONCOLOGY | PARTICIPATION | Biopsy | Carcinoma, Non-Small-Cell Lung | Humans | Biomarkers | Lung Neoplasms | Neoplasms | Precision Medicine | Medicine | Medical research | Lung cancer | Diagnostic software | Clinical trials | Non-small cell lung carcinoma | Diagnostic systems | Thorax
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 22, pp. 2965 - 2971
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2006, Volume 58, Issue 3, pp. 177 - 189
Proteasome inhibition is a novel therapeutic approach that is being investigated in non-small cell and small cell lung cancer (NSCLC and SCLC). Proteasome... 
SCLC | 26S proteasome | Bortezomib | NSCLC | Combination therapy | Docetaxel | MULTIPLE-MYELOMA | INDUCED APOPTOSIS | CELL-LINES | PHASE-III TRIAL | TUMOR XENOGRAFTS | ONCOLOGY | docetaxel | REFRACTORY MYELOMA | combination therapy | NON-HODGKINS-LYMPHOMA | COMBINATION CHEMOTHERAPY | bortezomib | HEMATOLOGY | NF-KAPPA-B | P27(KIP1) EXPRESSION | Proteins | Cell research | Lung cancer, Non-small cell
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 21, pp. 3543 - 3551
Journal Article